[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 23, Issue 3 (9-2021) ::
2021, 23(3): 190-202 Back to browse issues page
Effects of SARS-CoV-2 Virus on Thyroid Function: A Narrative Review
B Mahdavi , S.A Razavi
Department of Research and Development (R&D), Saeed Pathobiology & Genetics Laboratory, Tehran, I.R. Iran , s.adeleh.razavi@gmail.com
Abstract:   (3162 Views)
SARS-CoV-2 is a type of coronavirus that causes COVID-19 disease. The virus can infect various organs by triggering hormones, regulatory and messenger molecules, and immune-inflammatory responses. Given the vital role of thyroid in metabolism, it is important to understand the potential effects of SARS-CoV-2 on the thyroid gland. In this article, reports and studies examining the effects of SARS-CoV-2 infection on thyroid are reviewed, and possible effects of this virus on thyroid function are discussed. According to the available evidence, SARS-CoV-2 can adversely impact thyroid function directly by affecting the pituitary-thyroid axis or indirectly by triggering immune-inflammatory responses. COVID-19-dependent thyroid disorders have been biochemically observed in three forms: hypothyroidism, thyrotoxicosis, and nonthyroidal illness syndrome. Subacute thyroiditis has been one of the most common clinical conditions of SARS-CoV-2-dependent thyrotoxicosis. In addition, SARS-CoV-2 may cause recurrence of improved thyroid diseases or exacerbate current diseases. There is no evidence that thyroid disease, including thyroid cancer, increases the risk of COVID-19 or exacerbates its complications. According to current studies, COVID-19 medications, including glucocorticoids and anticoagulants, have no adverse effects on thyroid function in non-acute COVID-19 patients. Further studies are needed to investigate the interactions between SARS-CoV-2 infection and thyroid function.
Keywords: COVID-19, Hypothyroidism, Pandemic, SARS-CoV-2, Thyroid gland
Full-Text [PDF 873 kb]   (621 Downloads)    
Type of Study: Review | Subject: Endocrinology
Received: 2021/10/16 | Accepted: 2022/04/24 | Published: 2021/09/1
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mahdavi B, Razavi S. Effects of SARS-CoV-2 Virus on Thyroid Function: A Narrative Review. Iranian Journal of Endocrinology and Metabolism 2021; 23 (3) :190-202
URL: http://ijem.sbmu.ac.ir/article-1-2915-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 3 (9-2021) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4660